Andrew Green

Vaccines Medical Lead

Sector: Hospital & Health Care

Member Since, September 18, 2023

Open To Work

  • I am open to relocating to
  • I am open to working remotely Yes
  • I am open to being contacted by employers and recruiters Yes

About Me

I am a clinician scientist with over a decade of clinical, regulatory, and research experience in hospitals, health centres, and regulatory agencies.

I completed my residency in Preventive Medicine with a focus on health policy, regulatory science and pharmaco-economics. In addition to my clinical practice, I have regulatory experience at HSA and CoRE (Duke-NUS), and now I am putting my public health knowledge to good work as a regional medical lead in Takeda Vaccines.

I also have a strong scientific and research track record with published white papers and studies across topics including advanced therapy and precision medicine, regulatory capacity, digital health, and health product e-commerce. Finally, I am currently undertaking an MBA to round out my experience.



  • Master of Public Health - MPH ( - 2015) National University of Singapore

    Activities and societies: Recipient of Ministry of Health/Ministry of Education scholarship

  • Doctor of Medicine - MD ( - 2012) Duke-NUS Medical School

    Activities and societies: Recipient of Duke-NUS stipend

  • Master of Science - MS, Cognitive and Behavioural Neuroscience ( - 2008) University of Tübingen

    Activities and societies: Recipient of Max Plank stipend

  • Bachelor of Science - BS, Biomedical Sciences, Neuroscience ( - 2006) University of Melbourne

Work & Experience

  • Takeda (2023 - Present ) Vaccines Medical Lead (Growth and Emerging Markets)

    In charge of vaccine medical activities in Latin American and Asia-Pacific countries

  • Takeda (2021 - 2023 ) Vaccines Medical Lead (APAC)

  • Takeda (2020 - 2021 ) Medical Director (Vietnam, Malaysia, Philippines, Singapore Cluster)

  • Centre of Regulatory Excellence (2018 - 2019 ) Associate Consultant

    • Driving regulatory convergence across Asia-Pacific by orchestrating collaboration and relationship-building between regional health players (national regulatory agencies, health ministries, pharmaceutical and biomedical companies). Organising closed-door meetings, conferences, symposia, and negotiations. • Building regional knowledge base on current health topics, regulatory landscape, issues, and policy recommendations through white papers. Authored white papers on Advanced Therapy in South-East Asia, digital health, and orphan diseases networks. • Managing 6 support staff to drive curriculum development and delivery for the Graduate Certificate in Pharmaceutical Regulation, the first dedicated regulatory training in Asia. Liaising with content experts to identify key concepts and learning outcomes, designing delivery plan based on adult learning framework, and facilitating teaching sessions. Developed graduate teaching modules on Fundamentals of Pharmaceutical Regulation, Chemistry, Manufacturing and Controls, and Biotherapeutics. • Trained and taught junior residents and medical students, both by practical instruction during clinical work as well as weekly teaching sessions on epidemiology, biostatistics, and health policy. Sat on Duke-NUS Medical School’s Student Promotion Committee to support students facing roadblocks.

  • Centre of Regulatory Excellence (2017 - 2018 ) Senior Resident

  • Health Sciences Authority (2016 - 2017 ) Senior Resident

    • Responsible for the drafting, and implementation of Singapore’s national regulatory framework for Cell, Tissue, and Gene Therapy Products, due for enactment in 2019. In charge of engaging stakeholder groups of doctors, pharmaceutical companies, and regulators from other countries. • Acted as sole clinical representative on weekly Clinical Trials Peer Review to evaluate clinical trial applications from local and multinational pharmaceutical companies, focusing on clinical, design, ethics, and biostatistics aspects. • Drove multiple research studies currently in process of publication. Topics included health product e-commerce and drug lag.

  • Health Sciences Authority (2016 - 2016 ) Resident

  • National University Health System (2013 - 2016 ) Resident

    • Completed rotations across: - Occupational Medicine | Singapore General Hospital | Jul – Dec 2015 - Regulatory Science | Health Sciences Authority | Jan – Jun 2015, Jan – Jun 2016 - Clinical Epidemiology | Communicable Disease Centre | Apr – Dec 2014 - Infectious Diseases | Communicable Disease Centre | Jan – Mar 2014 - Family Medicine | Toa Payoh Polyclinic | Jul – Dec 2013

  • SingHealth (2012 - 2013 ) House Officer

    • Completed rotations across: - Obstetrics & Gynaecology | Singapore General Hospital | May – Jun 2013 - Orthopaedics | Singapore General Hospital | Jan – Apr 2013 - Psychiatry | Singapore General Hospital | Nov - Dec 2012 - Internal Medicine | Singapore General Hospital | Jul – Oct 2012